CENTAGEN

Serial Number 97980668
Registration 7986312
700

Registration Progress

Application Filed
Jun 17, 2022
Under Examination
Feb 13, 2024
Approved for Publication
Dec 19, 2023
Published for Opposition
Dec 19, 2023
Registered
Oct 14, 2025

Trademark Image

CENTAGEN

Basic Information

Serial Number
97980668
Registration Number
7986312
Filing Date
June 17, 2022
Registration Date
October 14, 2025
Published for Opposition
December 19, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 14, 2025
Registration
Registered
Classes
042

Rights Holder

Centagen, Inc.

03
Address
637 S Broadway St, Ste B-206
Boulder, CO 80305

Ownership History

Centagen, Inc.

Original Applicant
03
Boulder, CO

Centagen, Inc.

Owner at Publication
03
Boulder, CO

Centagen, Inc.

Original Registrant
03
Boulder, CO

Legal Representation

Attorney
Aileen Law

USPTO Deadlines

Next Deadline
2086 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251014)
Due Date
October 14, 2031
Grace Period Ends
April 14, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Oct 14, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 14, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 19, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 19, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 16, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 13, 2025 IUAF S USE AMENDMENT FILED Loading...
Sep 16, 2025 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Feb 13, 2025 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Sep 3, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 13, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Apr 30, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 13, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 12, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 12, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 12, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 13, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 19, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 19, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 29, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 13, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 13, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 12, 2023 ALIE A ASSIGNED TO LIE Loading...
Jun 8, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 6, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Biochemical research; Biochemical research and development; Biotechnology research; Pharmaceutical research and development; Research and development in the field of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cardiovascular, immune system and inflammatory related diseases and disorders; Scientific research; Stem cell research services; Research and development of pharmaceuticals for the treatment of age-related diseases
First Use Anywhere: Mar 3, 2009
First Use in Commerce: Jun 28, 2010

Classification

International Classes
042